Resideo Technologies Inc (REZI)
Official siteINDUSTRIALS • INDUSTRIAL DISTRIBUTION • NYSE
Market Cap: $3.24B
Last updated: Nov 17, 2026 at 11:06 AM ET
Resideo Technologies Inc (REZI) Financials: Revenue, Profit and Cash Flow
Resideo Technologies reported revenue of $7.47B for the fiscal year ended Dec 31, 2025, up 10.5% from the year before. That year, net income was -$527.00M with a net margin of -7.1%, operating cash flow was -$1.14B and free cash flow was -$1.25B. The quarter ended Sep 30, 2026 had revenue of $727.00M and net income of $22.00M.
Revenue and Margins
The operating margin was 8.1% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $4.46B, a compound annual rate of 5.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $7.47B | +10.5% | 29.4% | 8.1% | -7.1% |
| Dec 2024 | $6.76B | +8.3% | 28.1% | 7.7% | 1.7% |
| Dec 2023 | $6.24B | -2.0% | 27.2% | 8.8% | 3.4% |
| Dec 2022 | $6.37B | +9.0% | 27.7% | 9.6% | 4.4% |
| Dec 2021 | $5.85B | +15.3% | 27.1% | 9.6% | 4.1% |
| Dec 2020 | $5.07B | +1.7% | 26.5% | 6.1% | 0.7% |
| Dec 2019 | $4.99B | +3.3% | 25.6% | 5.2% | 0.7% |
| Dec 2018 | $4.83B | +6.8% | 29.5% | 10.2% | 8.4% |
| Dec 2017 | $4.52B | +1.4% | 29.1% | 9.8% | -8.7% |
| Dec 2016 | $4.46B | N/A | 30.6% | 11.1% | 4.0% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, net income fell 85.9% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.47B | $6.76B | $6.24B | $6.37B | $5.85B | $5.07B | $4.99B | $4.83B | $4.52B | $4.46B |
| Cost of revenue | $5.28B | $4.86B | $4.55B | $4.60B | $4.26B | $3.73B | $3.71B | $3.40B | $3.20B | $3.09B |
| Gross profit | $2.20B | $1.90B | $1.70B | $1.77B | $1.58B | $1.34B | $1.28B | $1.43B | $1.32B | $1.36B |
| Research and development | $167.00M | $111.00M | $109.00M | $111.00M | $86.00M | $74.00M | $0 | $0 | $0 | $0 |
| Operating income | $607.00M | $520.00M | $547.00M | $611.00M | $559.00M | $311.00M | $258.00M | $493.00M | $445.00M | $495.00M |
| Net income | -$527.00M | $116.00M | $210.00M | $283.00M | $242.00M | $37.00M | $36.00M | $405.00M | -$394.00M | $177.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $727.00M | $1.98B | $1.91B | $1.90B | $703.00M | $1.94B | $1.77B | $1.86B | $1.83B | $1.59B | $1.49B | $1.54B |
| Gross profit | $294.00M | $595.00M | $551.00M | $560.00M | $284.00M | $569.00M | $511.00M | $530.00M | $524.00M | $447.00M | $400.00M | $425.00M |
| Operating income | $72.00M | $131.00M | $102.00M | $140.00M | $106.00M | $177.00M | $136.00M | $144.00M | $126.00M | $122.00M | $128.00M | $147.00M |
| Net income | $22.00M | $97.00M | $38.00M | $136.00M | $156.00M | -$825.00M | $6.00M | $23.00M | $20.00M | $30.00M | $43.00M | $82.00M |
Balance Sheet
As of Dec 2025, total debt of $3.22B exceeded cash and equivalents by $2.69B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $8.43B | $8.20B | $6.64B | $6.39B | $5.85B | $5.61B | $5.13B | $4.97B | $4.47B | $4.29B |
| Current assets | $3.36B | $3.17B | $2.74B | $2.50B | $2.54B | $2.23B | $1.78B | $1.81B | $1.39B | $1.27B |
| Cash and equivalents | $537.00M | $692.00M | $636.00M | $326.00M | $775.00M | $517.00M | $122.00M | $265.00M | $56.00M | $47.00M |
| Total liabilities | $5.52B | $4.89B | $3.90B | $3.86B | $3.60B | $3.62B | $3.53B | $3.44B | $1.87B | $1.42B |
| Short-term debt | $57.00M | $51.00M | $51.00M | $12.00M | $10.00M | $7.00M | $22.00M | $22.00M | $0 | $392.00M |
| Long-term debt | $3.17B | $1.98B | $1.40B | $1.40B | $1.22B | $1.16B | $1.16B | $1.18B | $0 | N/A |
| Shareholder equity | $2.92B | $3.31B | $2.75B | $2.53B | $2.25B | $1.99B | $1.60B | $1.53B | $2.60B | $2.87B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $4.14B | $8.78B | $8.21B | $8.43B | $8.19B | $8.52B | $8.07B | $8.20B | $8.13B | $7.98B | $6.52B | $6.64B |
| Total liabilities | $3.19B | $5.78B | $5.29B | $5.52B | $5.42B | $5.90B | $4.73B | $4.89B | $4.78B | $4.69B | $3.75B | $3.90B |
| Cash and equivalents | $229.00M | $549.00M | $438.00M | $661.00M | $345.00M | $753.00M | $577.00M | $692.00M | $531.00M | $413.00M | $603.00M | $636.00M |
| Shareholder equity | $947.00M | $3.01B | $2.92B | $2.92B | $2.77B | $2.61B | $3.35B | $3.31B | $3.35B | $3.29B | $2.77B | $2.75B |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.14B | $444.00M | $440.00M | $152.00M | $315.00M | $244.00M | $23.00M | $462.00M | $37.00M | $151.00M |
| Capital expenditures | $116.00M | $80.00M | $105.00M | $85.00M | $63.00M | $70.00M | $95.00M | $81.00M | $51.00M | $60.00M |
| Free cash flow | -$1.25B | $364.00M | $335.00M | $67.00M | $252.00M | $174.00M | -$72.00M | $381.00M | -$14.00M | $91.00M |
| Dividends paid | $35.00M | $12.00M | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A |
| Share repurchases | $0 | $1.00M | $41.00M | $0 | $0 | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | -$39.00M | -$1.41B | -$44.00M | -$764.00M | -$65.00M | -$103.00M | -$112.00M | -$74.00M | -$51.00M | -$191.00M |
| Financing cash flow | $1.13B | $1.03B | -$64.00M | $170.00M | $20.00M | $253.00M | -$53.00M | -$167.00M | $21.00M | $4.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.00M | $148.00M | -$145.00M | $299.00M | -$1.57B | $200.00M | -$65.00M | $203.00M | $147.00M | $92.00M | $2.00M | $263.00M |
| Capital expenditures | $3.00M | $29.00M | $36.00M | $37.00M | $8.00M | $20.00M | $31.00M | $22.00M | $22.00M | $15.00M | $21.00M | $31.00M |
| Free cash flow | -$2.00M | $119.00M | -$181.00M | $262.00M | -$1.58B | $180.00M | -$96.00M | $181.00M | $125.00M | $77.00M | -$19.00M | $232.00M |
Frequently Asked Questions About REZI
What is Resideo Technologies' annual revenue?
Resideo Technologies reported revenue of $7.47B for the fiscal year ended Dec 31, 2025.
How fast is Resideo Technologies' revenue growing?
Revenue was up 10.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 5.5%.
Is Resideo Technologies profitable?
No. Resideo Technologies reported net income of -$527.00M for the fiscal year ended Dec 31, 2025, with a net margin of -7.1%.
How much free cash flow does REZI generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$1.14B minus capital expenditures of $116.00M produced free cash flow of -$1.25B.
How much debt does Resideo Technologies have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $3.17B, short-term debt of $57.00M and cash and equivalents of $537.00M.
REZI pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts